Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) ...

Research on hormone therapy reveals critical insights into cardiovascular disease risks, guiding clinicians in selecting ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...

A study reveals women with hypertensive disorders of pregnancy have a higher risk of coronary artery disease and myocardial ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite outcome of mortality, myocardial infarction, or stroke in patients with acute ...

Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...

Philippine Health Insurance Corporation (PhilHealth) announced on Monday new benefit packages covering various illnesses as ...

Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...

Risk for all-cause mortality and MACEs are affected by calcified and low-attenuation plaque burdens in patients with chronic kidney disease.

BusinessWire India Mumbai Maharashtra [India] 3 SMT Sahajanand Medical Technologies a global leader in cardiovascular devices ...